The Use of Somatropin (Recombinant Growth Hormone) in Children of Short Stature

Author： Mehta A.   Hindmarsh P.C.  

Publisher： Adis International

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.4, Iss.1, 2002-01, pp. : 37-47

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparative Study of Growth Hormone Treatment in Children with Idiopathic Short Stature and Growth Hormone Deficiency

By  

Current Drug Metabolism, Vol. 16, Iss. 10, 2015-12 ,pp. : 940-946

Bentham Science Publishers

Access to resources Recommend Favorite

Role of somatropin in idiopathic short stature unclear

By  

Inpharma, Vol. 1, Iss. 1334, 2002-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Sandoz' somatropin [recombinant human growth hormone; Omnitrope] has received marketing authorisation

By  

Inpharma, Vol. 1, Iss. 1463, 2004-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Growth Velocity, Final Height and Bone Mineral Metabolism of Short Children Treated Long Term with Growth Hormone

By  

Current Pharmaceutical Biotechnology, Vol. 1, Iss. 1, 2000-07 ,pp. : 33-46

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical applications of recombinant human growth hormone in adults

By Iglesias P.   Díez J.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 1, 1999-11 ,pp. : 97-107

Informa Healthcare

Access to resources Recommend Favorite